Quality Assurance and Clinical at ZimVie

The wisdom of Benjamin Franklin that “If you fail to plan, you plan to fail” still rings true in virtually every sector of business, especially in the highly regulated world of medical devices and healthcare.

Within our industry, an all-too-common perception is that quality and regulatory processes are barriers to market entry. However, with foresight and proper planning, they can actually be strategic springboards to accelerate market expansion and product adoption. Balancing the need for regulatory compliance with the desire to access markets with high potential is essential for success.

Most organizations historically began with either the U.S. or the EU as their ‘first’ market entries. This was for two reasons—first, the opportunity. With literally millions of patients in each of these markets, both are definitely deep pools to begin commercialization. Additionally, the ‘rules’ for getting into these markets were clear; in the U.S., the FDA pathways of 510(k) and PMA are relatively straightforward. But, with the 2017 ratification of the (EU) 2017/745 regulation by the European Parliament, (affectionately EUMDR) requiring more clinical evidence, the need for demonstrated clinical benefit, more data around biocompatibility and cleaning, and tighter requirements around what is or isn’t a change, getting to market became increasingly difficult in Europe.

In 2017, the World Health Organization (WHO) published a global regulatory framework for medical devices and in vitro diagnostics. This document was drafted and intended for regulators worldwide to develop harmonized considerations for the regulation of medical devices. Although the WHO does not regulate, nor do they provide oversight, there is a vested interest in ensuring that safe and effective medical devices are available for the benefit of patients around the world. At the time of the first data gathering, 62% of the participating countries had a legal framework for regulating devices. As of 2022, the WHO published its Global Medical Device Atlas, with 177 member countries participating and 82% now having a regulatory framework for bringing medical devices to their residents. This is quite a marked increase in expectations over a brief five-year period. With businesses desiring to expand globally, visibility into these additional markets must become an essential element of our design and development planning lifecycle.

"By understanding global economic opportunities and prioritizing markets with the lowest regulatory burden while maximizing opportunities for growth, companies can enhance their chances of success in the increasingly competitive healthcare landscape."

When considering market entry strategies, it's essential to identify regions with relatively low regulatory burdens while still maintaining adequate standards for safety and efficacy. Emerging markets in Asia, Latin America, and parts of Africa often offer more streamlined regulatory pathways compared to mature markets like the U.S. and EU. Countries such as India, Brazil, and China have established regulatory agencies that are actively working to harmonize their standards with international guidelines while also facilitating expedited approval processes for certain medical devices.

Assessing Market Potential:

While minimizing regulatory burden is a crucial factor in market entry decisions, it's equally important to evaluate the potential market size and demand. Factors such as population demographics, healthcare infrastructure, disease prevalence, and purchasing power all contribute to market potential. Emerging economies with growing middle-class populations and increasing healthcare expenditures present attractive opportunities for medical device companies. Additionally, niche markets with unmet medical needs or underserved patient populations may offer significant growth potential for innovative devices. Back to the WHO World Atlas: Let’s say your target therapy depends on the utilization of CT or other technology, such as X-ray or MRI, to determine a clinical endpoint. The World Atlas details the number of CT scanners per million residents. Knowing this information can help you contribute to developing your organization’s overall launch strategy. 

Strategies for Successful Market Entry:

To successfully enter the medical device market while balancing regulatory burden and market potential, companies can employ several strategies:

1. Prioritize markets with established regulatory pathways that align with the product's classification and intended use.

2. Leverage regulatory harmonization initiatives such as EUMDR to streamline approval processes across multiple markets simultaneously.

3. Collaborate with local regulatory experts and consultants to navigate complex regulatory requirements efficiently.

4. Focus on product innovation and differentiation to address specific needs and preferences of target markets with insights into available local technologies.

5. Build partnerships with local distributors, healthcare providers, and key opinion leaders to facilitate market access and adoption.

Case Study: Key Medical Device Manufacturer Enters the Indian Market

A key medical device manufacturer—let’s call them XYZ Medical Devices—a U.S.-based medical device company, identified India as a strategic market due to its large population, expanding healthcare infrastructure, and favorable regulatory environment. Leveraging its expertise in minimally invasive surgical devices, XYZ developed a novel laparoscopic instrument tailored to the needs of Indian surgeons.

By working closely with regulatory consultants in India, XYZ navigated the regulatory approval process efficiently, obtaining necessary certifications from the Central Drugs Standard Control Organization (CDSCO) within a reasonable timeframe. Additionally, XYZ established partnerships with local distributors and key opinion leaders to promote its product and provide training and support to healthcare providers.

As a result of its focused market entry strategy, XYZ Medical Devices successfully launched its laparoscopic instrument in India, capturing a significant share of the market and laying the foundation for future growth in the region.

Conclusion:

Navigating the medical device market requires a strategic approach that balances regulatory compliance with market potential. By understanding global economic opportunities and prioritizing markets with the lowest regulatory burden while maximizing opportunities for growth, companies can enhance their chances of success in the increasingly competitive healthcare landscape. Through careful planning, collaboration, and innovation, medical device companies can effectively penetrate new markets and deliver impactful solutions to patients and healthcare providers worldwide.